Årsrapport 2010 - Dansk Nefrologisk Selskab
Årsrapport 2010 - Dansk Nefrologisk Selskab
Årsrapport 2010 - Dansk Nefrologisk Selskab
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
4 <strong>Dansk</strong> <strong>Nefrologisk</strong> <strong>Selskab</strong>s Landsregister, <strong>Årsrapport</strong> <strong>2010</strong><br />
Klinisk epidemiologisk kommentar ........................................................................................................ 53<br />
DNSL’s kommentarer til indikator 3 ....................................................................................................... 54<br />
7.5. INDIKATOR 4. GRAFTOVERLEVELSE / GRAFT SURVIVAL ...................................................................................... 56<br />
Klinisk epidemiologisk kommentar til Indikator 4b ................................................................................ 56<br />
Klinisk epidemiologisk kommentar til Indikator 4b ................................................................................ 57<br />
DNSL’s kommentarer til indikator 4 ....................................................................................................... 57<br />
Indikator 4a. Etårs graftoverlevelse efter første nyretransplantation / One-year graft survival following<br />
the first renal transplantation ................................................................................................................ 58<br />
Indikator 4b. Femårs graftoverlevelse efter første nyretransplantation / Five-year graft survival<br />
following the first renal transplantation ................................................................................................ 61<br />
7.6. INDIKATOR 5. TRANSPLANTATION – PATIENTOVERLEVELSE / TRANSPLANTATION – PATIENT SURVIVAL ........................ 64<br />
Klinisk epidemiologisk kommentar til indikator 5a ................................................................................ 64<br />
DNSL’s kommentarer til indikator 5 ....................................................................................................... 64<br />
Indikator 5a. Etårs patientoverlevelse efter første nyretransplantation / One-year patient survival<br />
following the first renal transplantation ................................................................................................ 65<br />
Indikator 5b. Femårs patientoverlevelse efter første nyretransplantation / Five-year patient survival<br />
following the first renal transplantation ................................................................................................ 68<br />
KAPITEL 8. ERA-EDTA INDIKATORER / ERA-EDTA INDICATORS .................................................................. 71<br />
KAPITEL 9. SÆRRAPPORT. PROGNOSE 2011-2020/ PROGNOSIS 2011-2020 .............................................. 79<br />
9.1. PRINCIPPERNE BAG PROGNOSEMODELLEN ...................................................................................................... 79<br />
9.2. FORUDSÆTNINGERNE ................................................................................................................................ 80<br />
9.3. PROGNOSEN ............................................................................................................................................ 81<br />
9.4. KONKLUSION ............................................................................................................................................ 84<br />
KAPITEL 10. SÆRRAPPORT. DIALYSEFORM OG OVERLEVELSE: ÆNDRINGER 1990-<strong>2010</strong> / DIALYSIS<br />
MODALITY AND SURVIVAL: TRENDS 1990-<strong>2010</strong> ........................................................................................ 85<br />
10.1. INTRODUKTION ....................................................................................................................................... 85<br />
10.2. PATIENTER OG METODER .......................................................................................................................... 85<br />
10.3. RESULTATERNE ....................................................................................................................................... 86<br />
10.4. KOMMENTARER ...................................................................................................................................... 86<br />
KAPITEL 11. SÆRRAPPORT. CHARLSON KOMORBIDITETSINDEKS (CCI) FOR DNSL PATIENTER / CHARLSON<br />
COMORBIDITY INDEX FOR DNR PATIENTS ................................................................................................ 89<br />
11.1. KORT OM INDEKSET ................................................................................................................................. 89<br />
11.2. CHARLSONS KOMORBIDITETSINDEKS FOR INCIDENTE DNSL-PATIENTER / CCI FOR INCIDENT DNR PATIENTS, 1990-<strong>2010</strong><br />
.................................................................................................................................................................... 90<br />
Komorbiditet (Charlsons indeks) for incidente DNSL-patienter fordelt på patientens alder ved første<br />
behandling / CCI for incident DNR patients according to age, 1990-<strong>2010</strong> ............................................ 91<br />
Komorbiditet (Charlsons indeks) for incidente DNSL-patienter beregnet for forskellige skæringsdatoer<br />
(dato for første journalnotat vs. dato for første behandling) / CCI according to referral date and ESRD<br />
date, 2006-<strong>2010</strong> ..................................................................................................................................... 91<br />
11.3. LPR- VS. DNSL-REGISTRERINGER: BETRAGTNINGER OM VALIDITET / LPR- VS. DNSL-REGISTRATIONS: REFLECTIONS ON<br />
VALIDIDY ........................................................................................................................................................ 93<br />
11.4. REFERENCER .......................................................................................................................................... 94<br />
KAPITEL 12. SUPPLERENDE ANALYSER VED KOMPETENCECENTER SYD / SUPPLEMENTARY ANALYSES ..... 95<br />
12.1. SUPPLERENDE MORTALITETSANALYSE I FORBINDELSE MED INDIKATOR 3./SUPPLEMENTART ANALYSIS FOR INDICATOR 3<br />
.................................................................................................................................................................... 95
Change language